The U.S. Trustee, the bankruptcy arm of the Justice Department, will appoint one or more committees to represent the interests of creditors and stockholders in working with the company to develop a plan of reorganization to get out of debt.
Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH).
The plan outlines a new approach to funding stem cell research, one that supports and accelerates research projects to the next stage and ultimately accelerates the development of stem cell treatments to patients with unmet medical needs. Before joining CIRM, Mills was the President and CEO of Osiris Therapeutics. Under his leadership, Osiris developed the worldâs first approved stem cell drug, Prochymal, used for the treatment of acute graft-vs-host disease in children, a devastating complication of bone marrow transplantation that can be fatal.